• Aucun résultat trouvé

B-cell non-Hodgkin lymphoma

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

... and B- cell non-Hodgkin lymphomas ...with B-NHL is ...with B- NHL enrolled in a nationwide observational survey compared with 94 matched HCV- infected controls without ...and ...

17

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non- Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non- Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

... Introduction B-cell non-Hodgkin lymphoma (NHL) originates from B lymphocytes at various stages of differentiation, from precursor to mature ...with B-cell NHL are ...

15

Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells

Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells

... large cell lymphoma (ALCL) and classical Hodgkin lymphoma (cHL) are lymphomas that contain CD30-expressing tumor cells and have numerous pathological ...the Hodgkin and Reed-Sternberg ...

17

Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study

Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study

... E-mail: benedicte.deau-fischer@aphp.fr Summary Tandem stem cell transplantation (SCT) is an option for high-risk relapsed/refractory Hodgkin Lymphoma (HL) patients. We evaluated the ...

9

Concomitant nodal involvement by Langerhans Cell Histiocytosis and Hodgkin Lymphoma

Concomitant nodal involvement by Langerhans Cell Histiocytosis and Hodgkin Lymphoma

... • Practicians should be aware of the possibility of the combination of LCH with Hodgkin lymphoma, since both diseases can take the same clinical form, and yet have a very different prognosis. • Diagnosis of ...

1

Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination

Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination

... tumor B lymphocytes circulate around the body via the lymphatic system and ...DLBCL cell lines and reveal, using pharmacological and expression knockdown approaches, that Orai1/STIM1 channels are major ...

18

Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii

Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii

... developed B-cell non-Hodgkin lymphoma ...follicular lymphoma was diagnosed on a retroperitoneal biopsy (Figure ...the lymphoma recurred one year after doxycycline was ...

3

en
                                                                    fr

en fr PATHOLOGICAL ROLE OF CHROMOSOME 1 PERICENTROMERIC HETEROCHROMATIN ANOMALIES IN NON-HODGKIN B-CELL LYMPHOMA ROLE PATHOLOGIQUE DES ANOMALIES DE L'HETEROCHROMATINE PERICENTROMERIQUE DU CHROMOSOME 1 DANS LES LYMPHOMES B MALINS NON-HODGKINIENS

... the lymphoma B cells presenting the aberrant heterochromatin foci (CH1), compared to control lymphoma cells, but this became less marked at the neighbouring genes (Figure ...the lymphoma ...

230

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

... of B-cells following their infection by ...and non-structural protein 3 (NS3) have been found to induce nitricoxide synthase (NOS) and reactive oxygen species (ROS) generation, which might be responsible ...

11

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

... Editor: B-cell receptor (BCR) signaling pathway inhibitors (including Bruton ’s tyrosine kinase [BTK] inhibitors, and phosphatidylinositol-3 kinase inhibitors [PI3Ki]) have shown clinical ef ficacy in ...

7

en
                                                                    fr

en fr Social inequalities impacts of care management and survival in patients with non-hodgkin lymphoma Rôle des inégalités sociales dans la prise en charge et la survie des lymphomes non hodgkiniens en population générale

... large B-cell lymphoma has increased during the last decade as a result of addition of anti- CD20 to anthracycline-based ...that non-biological factors play a ...large B-cell ...

230

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.: Molecular Signature of Hepatosplenic T-cell Lymphoma

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.: Molecular Signature of Hepatosplenic T-cell Lymphoma

... lupus, Hodgkin lymphoma or malaria 4 and more recently also after treatment with anti-TNF agents 36 ...and B-cell exit from lymphoid organs 37 ...NK cell trafficking in steady-state and ...

41

Gene expression-based risk score in diffuse large B-cell lymphoma.

Gene expression-based risk score in diffuse large B-cell lymphoma.

... develop lymphoma after a long latency[33]. In non-Hodgkin lymphoma, MCL1 expression was signiicantly lower in patients in complete remission than with progressive ...

12

Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.

Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.

... polymorphic B lymphoproliferative syndrome and an actual lymphoma 50 ...stem cell transplantation ...in cell lines carrying mutations in p110δ and p85α 9,11,12,54 ...indolent ...

17

A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever

A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever

... Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes ...

19

Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma

Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma

... large B-cell lymphoma Diffuse large B-cell lymphoma (DLBCL), representing 40% of non-Hodgkin lymphoma (NHL), is heterogeneous with respect to morphology, ...

12

Results from the Belgian mantle cell lymphoma registry

Results from the Belgian mantle cell lymphoma registry

... Mantle cell lymphoma is a B-cell non-Hodgkin’s lymphoma characterized by a t(11;14), resulting in overexpression of cyclin ...Mantle cell lymphoma (MCL) in Belgium, ...

8

Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

... both lymphoma cell lines and bi- opsies from NHL patients, indicating that targeting of the CD37 antigen with HH1 is clinically injected activity per gram of tissue ...

20

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

... lymphoblastoid cell lines (LCLs) derived from circulating normal B cells from 49 post-therapy HL patients and 25 unaffected controls using linear models to assess correlation between genotype and TCF3 ...

11

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis

... of non- Hodgkin lymphoma among adults, diffuse large B-cell lymphoma (DLBCL), but not in another type of mature aggressive B-cell lymphoma, Burkitt ...

13

Show all 10000 documents...

Sujets connexes